Sol-Gel Technologies Ltd. (SLGL)Healthcare | Biotechnology | Ness Ziona, Israel | NasdaqCM
73.91 USD
-0.04
(-0.054%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 73.91 +0.10 (0.135%) ⇧ (July 13, 2026, 4:10 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 4:31 a.m. EDT
The investment case for Sol-Gel Technologies is currently broken by a catastrophic multi-year decline in shareholder value. Despite a recent 30% price surge and a bullish analyst target implying a 150% upside, the underlying business has suffered five consecutive years of negative annual returns, with the last four being straight declines. This relentless downward trajectory, culminating in a nearly 87% loss of value since 2018, suggests the market has correctly identified severe structural deterioration in the company's ability to generate revenue or profits. The recent price rally appears to be a speculative reaction to a specific catalyst rather than a correction of fundamental value, leaving the stock exposed to further downside if that catalyst fails to materialize. With no dividend to provide income and a balance sheet showing negative operating margins and shrinking revenues, the security offers no safety margin for a long-term holder. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.035097 |
| AutoARIMA | 0.035368 |
| MSTL | 0.042354 |
| AutoTheta | 0.084269 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 31% |
| H-stat | 0.19 |
| Ljung-Box p | 0.003 |
| Jarque-Bera p | 0.024 |
| Excess Kurtosis | 1.22 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.677 |
| Revenue per Share | 6.598 |
| Market Cap | 239,857,920 |
| Forward P/E | -8.03 |
| Beta | 1.13 |
| Profit Margins | -5.66% |
| Website | https://www.sol-gel.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 8.040342 |
| Address1 | 7 Golda Meir Street |
| Address2 | Weizmann Science Park |
| All Time High | 210.0 |
| All Time Low | 3.34 |
| Ask | 75.0 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 28,910 |
| Average Daily Volume3 Month | 32,686 |
| Average Volume | 32,686 |
| Average Volume10Days | 28,910 |
| Beta | 1.126 |
| Bid | 73.71 |
| Bid Size | 1 |
| Book Value | 15.725 |
| City | Ness Ziona |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 73.91 |
| Current Ratio | 8.837 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 74.93 |
| Day Low | 73.755 |
| Debt To Equity | 1.677 |
| Display Name | Sol-Gel |
| Earnings Timestamp | 1,779,971,400 |
| Earnings Timestamp End | 1,787,315,400 |
| Earnings Timestamp Start | 1,787,315,400 |
| Ebitda | -2,300,000 |
| Ebitda Margins | -0.124560006 |
| Enterprise To Ebitda | -82.454 |
| Enterprise To Revenue | 10.271 |
| Enterprise Value | 189,645,120 |
| Eps Current Year | -8.525 |
| Eps Forward | -9.20333 |
| Eps Trailing Twelve Months | -0.3 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 73.003 |
| Fifty Day Average Change | 0.9070053 |
| Fifty Day Average Change Percent | 0.01242422 |
| Fifty Two Week Change Percent | 804.03424 |
| Fifty Two Week High | 97.97 |
| Fifty Two Week High Change | -24.059998 |
| Fifty Two Week High Change Percent | -0.24558535 |
| Fifty Two Week Low | 7.616 |
| Fifty Two Week Low Change | 66.29401 |
| Fifty Two Week Low Change Percent | 8.70457 |
| Fifty Two Week Range | 7.616 - 97.97 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,517,495,400,000 |
| Float Shares | 532,290 |
| Forward Eps | -9.20333 |
| Forward P E | -8.030789 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 28 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.09304 |
| Gross Profits | 1,718,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.59702 |
| Held Percent Institutions | 0.37317002 |
| Implied Shares Outstanding | 3,245,270 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,746,403,200 |
| Last Split Factor | 1:10 |
| Long Business Summary | Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel. |
| Long Name | Sol-Gel Technologies Ltd. |
| Market | us_market |
| Market Cap | 239,857,920 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_621569 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -1,046,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 241,741,884 |
| Number Of Analyst Opinions | 3 |
| Open | 74.93 |
| Operating Margins | -35.694443 |
| Payout Ratio | 0.0 |
| Phone | 972 8 931 3433 |
| Post Market Change | 0.1000061 |
| Post Market Change Percent | 0.13549127 |
| Post Market Price | 73.91 |
| Post Market Time | 1,783,973,405 |
| Previous Close | 73.95 |
| Price Eps Current Year | -8.669796 |
| Price Hint | 2 |
| Price To Book | 4.700159 |
| Price To Sales Trailing12 Months | 12.989868 |
| Profit Margins | -0.056649998 |
| Quick Ratio | 8.537 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0399933 |
| Regular Market Change Percent | -0.0540815 |
| Regular Market Day High | 74.93 |
| Regular Market Day Low | 73.755 |
| Regular Market Day Range | 73.755 - 74.93 |
| Regular Market Open | 74.93 |
| Regular Market Previous Close | 73.95 |
| Regular Market Price | 73.91 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 23,041 |
| Return On Assets | -0.03472 |
| Return On Equity | -0.02923 |
| Revenue Growth | -0.895 |
| Revenue Per Share | 6.598 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 3,245,270 |
| Shares Percent Shares Out | 0.0145000005 |
| Shares Short | 47,496 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 53,063 |
| Short Name | Sol-Gel Technologies Ltd. |
| Short Percent Of Float | 0.045100003 |
| Short Ratio | 1.42 |
| Source Interval | 15 |
| Symbol | SLGL |
| Target High Price | 285.0 |
| Target Low Price | 110.0 |
| Target Mean Price | 193.0 |
| Target Median Price | 184.0 |
| Total Cash | 52,828,000 |
| Total Cash Per Share | 16.16 |
| Total Debt | 862,000 |
| Total Revenue | 18,465,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.3 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 60.60438 |
| Two Hundred Day Average Change | 13.305622 |
| Two Hundred Day Average Change Percent | 0.21954885 |
| Type Disp | Equity |
| Volume | 23,041 |
| Website | https://www.sol-gel.com |
| Zip | 7,403,650 |